Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$ABMC only 15,229,338 shares available to trade.
Authorized Shares 50,000,000 05/12/2020
Outstanding Shares 35,847,093 05/12/2020
$ABMC shares recorded with SEC
Stuart Sternberg Amount beneficially owned: 2,428,671 shares Percent of class: 7.4% of 32,680,984 outstanding shares reported September 30, 2019
John J. Moroney Amount beneficially owned: 2,481,608 Percent of class: 7.6% 4/27/2020
John J. Moroney Amount beneficially owned: 3,457,011 Percent of class: 11.4% 10/24/2016
MP Biomedicals LLC Amount beneficially owned: 4,738,601 shares Percent of class: 18.2% ownership of ABMC 03/03/2016
Davis Chaim Buy 528,571 03/02/2020
Davis Chaim Buy 500,000 01/23/2019
Misc Directors 366,100
Totals- 13,600,562 shares held 41.6%
Plus unoffical ahares held by others on this board over 5%
Only 53.4% 19,142,347 shares left to trade.
Open to corrections or additions.
$ABMC less than 19,142,347 shares available to trade.
Authorized Shares 50,000,000 05/12/2020
Outstanding Shares 35,847,093 05/12/2020
$ABMC shares recorded with SEC
Stuart Sternberg Amount beneficially owned: 2,428,671 shares Percent of class: 7.4% of 32,680,984 outstanding shares reported September 30, 2019
John J. Moroney Amount beneficially owned: 2,481,608 Percent of class: 7.6% 4/27/2020
John J. Moroney Amount beneficially owned: 3,457,011 Percent of class: 11.4% 10/24/2016
MP Biomedicals LLC Amount beneficially owned: 4,738,601 shares Percent of class: 18.2% ownership of ABMC 03/03/2016
Davis Chaim Buy 528,571 03/02/2020
Davis Chaim Buy 500,000 01/23/2019
Misc Directors 366,100
Totals- 13,600,562 shares held 41.6%
Plus unofficial shares held by others on this board over 5%
Only 53.4% 19,142,347 shares left to trade.
$ABMC can easily trade this every two days or less, with the proper catalyst, such as the record shattering sales and profit figures.
Open to corrections or additions.
Thanks for the info. Good to let new ones on the board see what MM are doing here.
Evidence to readers that most of what looks like selling is actually buying. You have a great question.
By the MM printing every transaction that was entered at ask but them selling below ask or even at bid to look like you sold, is exactly why I wanted team $ABMC to disclose these transactions publicly on this board.
As explained above so well by tomj1, there just are not enough shares to have a balanced market for $ABMC, so they have to resort to legal manipulation to shake shares loose. I believe much of the spikes in volume was them getting shareholders excited (FOMO), selling short into those moves, and covering when they make those fast share price drops.
All in a day s work, and why I am not psychologically capable of doing a MM's job.
The real buying are the slow methodical buys we are seeing throughout the day which someone is accumulating below $1.00.
From the article:
It's obvious to our $ABMC team. Wake up people, you do not have to swab all players, just those that show positive on the $ABMC serology test.
It’s less than obvious, to say the least, how Major League Baseball plans to expand capacity for MLB COVID-19 tests while America as a whole is experiencing “a new testing crisis” and a “failure of the system.” At the very least it’s less than obvious how, even if Major League Baseball can do so, it can do so ethically.
https://mlb.nbcsports.com/2020/07/07/baseball-seeking-a-second-lab-for-mlb-covid-19-tests/
Unfortunate for society that you have to change views, but honest that you did so.
It seems our President will make us millionaires, nut just the billionaire making millionaires.
Trump: 'I disagree' with Fauci on COVID-19 in the US
"The current state is really not good," the highly respected Fauci, head of the National Institute of Allergy and Infectious Diseases, said in a Facebook and Twitter livestream on Monday.
"We are still knee deep in the first wave" of COVID-19 infections," he said.
Trump, speaking Tuesday in a TV interview, disagreed with Fauci, a key player on the White House's own Coronavirus Task Force.
"I think we are in a good place," the president said in an interview on the "Full Court Press" news show hosted by a former Fox News anchor, adding: "I disagree with him."
I am not very good on the course, but we can all set up a fishing date. We can fly anywhere in the world when $ABMC moves to $10.00
What kind of fishing do you like to do?
Quest Diagnostics and LabCorp 6 DAY WAIT FOR TEST RESULTS.
QD and LC have just announced that testing results have been stretched to 6 days. This means people have to stay in quarantine until their results and they are also becoming frustrated.
Their capacity has increased incredibly but they still can not keep up.
See $ABMC step in. We going to be so huge.
To me sb, a buy is a buy. If I fill on bid the ask or in between, I am still a long holder taking shares from a short term trader.
If I am on the bid, I would be building up the floor/support with bid size showing strength. If I buy at the ask we break down resistance at the ceiling so there is a benefit both ways.
BTW, even though I have been here since early April, I have rarely set an order for $ABMC below the ask so I don't have that personal experience on this ticker which is why I am asking all the ABMC'ers for your experiences.
Serious question for $ABMC buyers.
I would like to determine if MM are filling below your order prices to falsely make it look like there is selling instead of buying, therefore tempting some to really sell. I feel MM's need to accumulate shares for the next run and are doing some manipulation. (Which is legal).
Are you getting filled at the ask and then seeing your transaction on the ask in time and sales, or are you getting filled below your price, no matter what you are offering?
I would like to determine if MM are filling below your order prices to falsely make it look like there is selling instead of buying, therefore tempting some to really sell. I feel MM need to accumulate shares for the next run.
This burst of buying and then instant lack of volume is not typical from my experience over the years of watching level 2. Volume should typically fade in and then fade out at least into the next morning etc.
I never felt bad watching $DECN move up without me buying in. I agree with you that I am so comfortable with this $ABMC long hold, rather than fretting on when DECN will take a dump.
From research on the various ways of testing, it does not seem the $DECN metered blood test is valid, or at least will not be accurate. It was designed as a blood glucose meter after all.
The equivalent and newly approved $BDX - Becton Dickinson test is only in the 80% accuracy range and expensive to operate.
Fundamentally, investors would have already jumped all over this $DECN device if it were proven.
I have a negative rating on $DECN and other than hype, the floor would have dropped out already.
WHO Serology Test Results- World Health Association gives another proof of the $ABMC Healgen/OrientGene Covid-19 test kit superiority.
Thanks @rowles5050 for the find.
WHO Serology Test-
Clinical sensitivity and specificity of three rapid SARS-CoV-2 Antibody (IgM/IgG) Tests on a hospitalized patient cohort: InTec, Cellex and OrientGene
WHO report conclusion- compared to RT-PCR,
InTec product showed the highest overall sensitivity followed by OrientGene and Cellex.
InTec is a Chinese Company that is not FDA-EUA approved.
OrientGene is the $ABMC test one of the top tested kits.
Cellex is FDA EUA approved and ranks below Healgen in several tests.
Here is an easier to read link WHO test:
https://americaser.com/wp-content/uploads/2020/05/WHO-Clinical-sensitivity-and-specificity-of-three-RDTs_-report-ErasmusMC_fin....pdf
The FDA EUA approved tests and their results.
https://www.fda.gov/medical-devices/emergency-situations-medical-devices/eua-authorized-serology-test-performance
Yes, the poor $BDX performance is actually surprising at this late stage in development.
Also,the Becton Dickinson CEO realizes their test is very expensive at $20.00 per test. He tried to minimize the expense because it is 50% cheaper than the current PCR tests.
$ABMC should get some traction from this exposure when it is found to be better performing and at less cost.
I had an overly lazy weekend AdamS007. TY for asking.
I just added some drama to my post to get more eyes on the discussion ;-P. If there is any value in the discussion, I won't be able to follow it all.
$ABMC is still currently my most confident holding. Never a doubt
CNBC announced a serology test kit discussion at 1:00 EST based on the news of the newly FDA-EUA approved Becton Dickinson (BDX) serology test.
CNBC and the pres is acting as if this is revolutionary, which it is not, so I do not understand what manipulation is happening. I also heard a comment about the importance of opening stadiums using these tests.
Not much new info available for us on $PURE until the company announced more partnerships and/or guidance on revenues which we know will be another record breaking quarter.
Agreed, Market Making is 100% algorithms now. There is one person in the office validating that the computer transactions are not going the wrong way for the MM.
These algorithms know how to shake out shares by placing their own buys and sells and then buying or selling those same shares at a later date to profit on the spread. All this is done in pennies.
$ABMC is just trading so thin the moves are exagerated, just as they will be when the PR's begin to break.
TheRainbow
I have been watching the board for the short time I have invested looking for some info and and suddenly, today, it woke up.
Took me a while to read through everything. Where is all this energy from? (meant in a nice way)
I would hope she would outsource the PR work. It seems out of her natural realm for what I know of the company in the short time I have been doing DD.
If you notice, all of these newsletters use the same text. Perhaps you could write them for her.
$ABMC has the strongest sales territory in the U.S. and also has South America.
$ABMC has the region with the greatest COVID-19 problems and is the official distributor for the eastern seaboard, $AYTU handles midwest and Rocky Mountains and Confirm Biosciences a private company handles the west coast, Hawaii and Alaska.
i am curious to know who is handling these PR's.
True, I kinda meant that in a satirical way. And, that does not make it incorrect. ;-P
What a great day we had.
$ABMC COVID-19 FDA results posted for Rapid Test is one of only four with positive FDA results from a National Cancer Institute Evaluation of the Company’s Licensed COVID-19 IgG/IgM Rapid Test.
An independent validation study performed by the NCI.
96.7% and 100% sensitivity were estimated for IgG and IgM, respectively.
97.5% and 100% specificity were estimated for IgG and IgM, respectively.
Combined sensitivity and specificity were 100% and 97.5%, respectively.
$ABMC has a distribution agreement with Zhejiang Orient Gene rapid test. Emergency Use Authorization of the COVID-19 IgG/IgM Rapid Test Cassette was granted by the FDA on May 29, 2020 to Healgen Scientific, LLC, the U.S. subsidiary of manufacturer Zhejiang Orient Gene Biotech, Limited.
Independent Evaluations of COVID-19 Serological Tests
https://open.fda.gov/apis/device/covid19serology/
$ABMC Web site with the COVID-19 test
https://abmc.com/
Coronavirus (COVID-19) Update: FDA Publicly Shares Antibody Test Performance Data From Kits as Part of Validation Study
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-publicly-shares-antibody-test-performance-data-kits-part-validation
BTown, it is also announced that ICU's in many CA hospitals have greater admission numbers than the original spike, more young people are being admitted and although they are being released earlier, they are a major source of spread before being diagnosed.
Melissa agrees with tedpeele as does #ABMC and so do I. Perhaps I can summarize every post he made today.
Form Type—8-K 06/26/2020
https://www.otcmarkets.com/filing/html?id=14243345&guid=0u5FUKt5C5DXGyh
About American Bio Medica Corporation
American Bio Medica Corporation manufactures and markets accurate, cost-effective immunoassay test kits, primarily point of collection tests for drugs of abuse and distributes a rapid test to detect Covid-19 antibodies. The Company and its worldwide distribution network target the workplace, government, corrections, clinical and educational markets.
This release may contain forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results to differ, and such differences could be material. Such risks and uncertainties include, but are not limited to, risks and uncertainties related to the following: continued acceptance of our products, increased levels of competition in our industry, acceptance of new products, future sales and profit levels of the rapid antibody test for Covid-19 that we are distributing, product development, compliance with regulatory requirements, including but not limited to our ability to obtain marketing clearance on our product for our intended markets, intellectual property rights, our dependence on key personnel, third party sales and suppliers, trading in our common shares may be subject to “penny stock” rules, our history of recurring net losses and our ability to continue as a going concern. There can be no assurance that the Company will be successful in addressing such risks and uncertainties and the Company assumes no duty to update any forward-looking statements based upon actual results. Investors are strongly encouraged to review the section entitled “Risk Factors” in the Company's annual report on Form 10-K for the year ended December 31, 2018, quarterly reports on Form 10-Q, and other periodic reports on file with the Securities and Exchange Commission for a discussion of risks and uncertainties that could affect operating results and the market price of the Company's common shares.
5000 $ABMC COVID-19 test kits received in Ecuador on May 29 after MULTI GOVERNMENTAL AGENCY approval.
The picture shows how 5000 $ABMC tests kits is packaged.
http://www.guaranda.gob.ec/newsiteCMT/gad-guaranda-entrega-5-000-pruebas-rapidas-de-covid-19-a-la-direccion-distrital-de-salud/
GAD GUARANDA DELIVERS 5,000 QUICK TESTS OF COVID-19 TO THE DISTRICT HEALTH DIRECTORATE
05/29/2020 7:18 pm Communication Direction News 0 Comments
This Friday, May 29, 2020, the Municipality of Guaranda, through an inter-institutional agreement, delivered 5,000 rapid tests for the identification of Covid-19, multi-parameter equipment and biosafety supplies to the District Health Department 02D01.
"We earmarked more than $ 130,000 for the acquisition of supplies that allow health personnel to streamline the detection, control and reduction of coronaviruses in the canton. This is a budget that was initially intended for the execution of works, however, the most important thing is the life and well-being of our people, and now our priority is health, ”said Medardo Chimbolema, mayor of Guaranda.
This acquisition is part of Covid-19's Control and Mitigation Emergency Budget Item in the canton, which includes a budget of $ 891,094, of which 75,000 correspond to rapid tests. The remaining budget corresponds to the purchase of food kits, biosecurity equipment for front-line personnel and supplies for cleaning and disinfection in the canton.
Gustavo Camacho, District Director of Health 02D01 highlighted the co-responsibility of the Municipality of Guaranda with Public Health and citizen welfare where, each of the materials acquired will allow to identify new cases of contagion; treat stable covid-19 positive patients and avoid virus spread, he said.
After this delivery, the District Health Directorate 02D01 will be in charge of the application and distribution of biosafety supplies and rapid tests to the different medical units of the canton.
#GuarandaPuebloSolidario
#Stay at home
Source: Communication Directorate
Todays volume is +167% of average. Currently 1,232,175 shares vs average of 30 days of 735,729.
Share price +23%
We will get a better handle on factual COVID-19 test kit orders from the next Form 8-K expected before July 6.
Melissa gave revenues booked to date on the 8-K submitted 2020-06-26. She may do that again for the numbers booked to date of the next filing expected this week. This will give us an idea of revenue from kits sold, then extrapolate the difference in the two weeks between filings.
"...As of the date of this release, we have recorded revenues of just over $1,000,000 which resulted in approximately $430,000 in profit to ABMC after expenses and commissions.”
TheRainbow
Off topic again, AdamS007. Although there was severe damage, I am an ecologist and know the cycle of life and that fire is necessary and positive.
Unfortunately, the world is going through other cycles which we can all agree should be minimized as much as possible. We have a part of that solution right here.
Off topic, @AdamS007 Literally, It looks like that GIF was the fire over my house a few years back.
Pray a flair up of COVID-19 does not occur next season.
$ABMC as a distributor of the Healgen COVID-19 test may have greater sales as compared to $AYTU which seems to have put a lot of emphasis on a partnership for a second test by distributing Biolidics’ Covid-19 antibody test kits over the Healgen test.
Biolidics states both companies had mutually agreed to terminate an earlier distribution agreement for Biolidics’ Covid-19 antibody test kits in the US amid increased competition for such kits, Biolidics said on Sunday (June 28).
As a consequence, its current test kits will no longer be available in the US market, it said.
https://www.straitstimes.com/business/companies-markets/biolidics-calls-off-us-sale-of-covid-19-test-kits-to-develop-new-kit-with
Both companies want to pursue the development of a new test. The assumpution for this is that this could not be completed in the next several quarters.
You are very clear and your process is right on @sacco. A majority of companies only put out the great PR's to promote stock prices before an offering or to sell personal shares.
Ask the right questions and we ride out any of the manipulation that will cause us to sell. The $ABMC management is overly conservative and without AdamS007 and SPORTYNORTY SHARE PRICE WOULD STILL BE AT $0.15 moving up to $0.20
$ABMC as a distributor of the Healgen COVID-19 test must have greater sales as compared to $AYTU which seems to have put a lot of emphasis on a partnership for a second test by distributing Biolidics’ Covid-19 antibody test kits over the Healgen test.
Biolidics states both companies had mutually agreed to terminate an earlier distribution agreement for Biolidics’ Covid-19 antibody test kits in the US amid increased competition for such kits, Biolidics said on Sunday (June 28).
As a consequence, its current test kits will no longer be available in the US market, it said.
https://www.straitstimes.com/business/companies-markets/biolidics-calls-off-us-sale-of-covid-19-test-kits-to-develop-new-kit-with
Both companies want to pursue the development of a new test. The assumpution for this is that this could not be comleted in the next several quarters.
@SPORTYNORTY Great post, concise and easy to understand for newbies and all the current questioning ones.
I just realized that the potential/possible net profit for South America alone is larger than the number of shares outstanding for $ABMC.
10,800,000 test kits sold (older data) X $7.5= $80,250,000 x 43% net profit= $34,507,500
32,680,984 outstanding shares reported on the issuer’s 10-Q.
https://www.sec.gov/Archives/edgar/data/896747/000110465920076351/tm2023332d1-sc13g.htm
These are unheard of numbers.
TheRainbow
It is not the sales numbers $ABMC will receive from sport franchise clients that is the most important. It is the PR, product validation and free marketing that is of most value.
More importantly for the long term value of the company, the Covid-19 test is opening the doors to new clients for their manufactured and patented drug tests as well as other distributed products.
Finally, the experience and new relationships built up by $ABMC will work in our favor when the "next pandemic" hits.
TheRainbow
$ABMC management is so ultra conservative, reading the 10-K made my mouth dry as cotton. Even the great news of a financial turnaround, was made to sound as a non event.
Realize this was probably done not to bring down the wrath of the SEC on COVID-19 pumping. But the company certainly went to the opposite extreme.
In any case, PR's can now be released without anyone stubbing their toe.
rainbow
Finally someone understands the sales potential $ABMC will record.
From @bk1287 recorded revenues of just over $1,000,000 which resulted in approximately $430,000 in profits in basically four weeks and it’s just the beginning.
Four weeks of profit in a portion of a quarter which practically wiped out all company debt incurred in all of 2019.
rainbow